Profound abnormality of the B/T lymphocyte ratio during chemotherapy for pediatric acute lymphoblastic leukemia

Leukemia
T E CaverJ L Hurwitz

Abstract

The fluorescence-activated cell sorter (FACS) was utilized to phenotype lymphocyte compartments in children receiving intensive chemotherapy for acute lymphoblastic leukemia (ALL). Sixteen patients (eight males and eight females) of diverse ages, risks of relapse, and within weeks 7-53 of maintenance/continuation chemotherapy treatment were arbitrarily selected for study. All 16 patients had profound B cell lymphopenia. In contrast, T cell numbers were often normal or marginally low, and accounted for up to 98% of the lymphocyte populations. No abnormality in T cell phenotypes could be demonstrated. Due to the highly skewed B/T lymphocyte ratios in these ALL patients, the absolute white blood cell counts and lymphocyte percentages were not predictive of the underlying B cell lymphopenia. Patients were also tested for serum immunoglobulin levels and most had abnormally low IgG and IgM. None of four patients immunized with the 1996-1997 influenza virus vaccine seroconverted to at least two vaccine antigens as compared to 10 of 10 healthy, age-matched controls. In total, these data highlight for the first time the profound abnormality of the B/T lymphocyte ratio in patients during treatment for ALL, and argue for consideration of ...Continue Reading

Citations

Nov 10, 2012·Leukemia·C BohnstedtUNKNOWN Nordic Society of Pediatric Hematology and Oncology (NOPHO)
Sep 21, 2001·British Journal of Haematology·E D HeegaardK Schmiegelow
Mar 31, 2006·Cognitive Neuropsychiatry·D A Oakley
Feb 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Soonie R PatelPaul T Heath
Feb 25, 2000·Current Opinion in Oncology·C H Pui
Jul 13, 2002·Medical and Pediatric Oncology·Susanna SwilleyMelissa M Hudson
Jul 24, 2001·Medical and Pediatric Oncology·A PoulsenK Schmiegelow
Feb 16, 2016·European Journal of Medical Genetics·Kjeld Schmiegelow
Feb 5, 2008·Pediatric Clinics of North America·Soonie R PatelPaul T Heath
Jul 24, 2007·The Journal of Pediatrics·Hiroto InabaBassem I Razzouk
Jul 8, 2005·European Journal of Haematology·Simone Cesaro
Mar 30, 2004·Pediatric Blood & Cancer·Wlodzimierz LuczynskiMaryna Krawczuk-Rybak
Sep 14, 2007·Pediatric Blood & Cancer·Sofia KosmidisHelen Vasilatou-Kosmidis
May 29, 2014·BioMed Research International·Simone CesaroDésirée Caselli
Jan 19, 2012·Human Vaccines & Immunotherapeutics·Jonathan A McCullers, Victor C Huber
Aug 21, 2016·Pediatrics and Neonatology·Najwa Yahya FayeaShaimaa Mohamed Kandil
Dec 1, 2014·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Mingjuan LiuYongqing Zhang
Aug 21, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Vincenzo LionettiFabio A Recchia
Oct 23, 2020·Viral Immunology·Sebahat Cam, Mustafa Asim Yoruk
Feb 13, 2019·The Lancet Infectious Diseases·Malgorzata MikulskaUNKNOWN European Conference on Infections in Leukaemia group
Apr 21, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H InabaC-H Pui
Oct 16, 2010·The Lancet Oncology·Hiroto Inaba, Ching-Hon Pui

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.